Our take on the latest news and views on data.
Relevant company news, articles, podcasts, and blog posts.
Recent Posts
What do the big players have in store for the Diabetes market in the next 12 months?
Diabetes is one of the most prevalent diseases in the U.S., afflicting over 29 million people across Type 1 and Type 2 patients,...
New Faces in Big Pharma & the Rise of the Billion Dollar Deal
M&A mania is here. Unprecedented deal values for mergers and acquisitions dominated in 2014. Worldwide M&A was up...
Covid-19 Clinical Trials and Where to Get Treated
We all know the basics for fighting the COVID-19 virus, like washing our hands and staying socially distant from one another,...
Pharma Forecasting Case Study – Valuing the Impact of Development Delays
A multinational pharmaceutical firm asked Ozmosi to provide forecasts to assess the market impact of delays in delivering new...
Case Study Portfolio – Prioritization aligning teams on value and risk and guiding investment
The Asia-Pacific R&D unit of a large, multinational pharmaceutical company needed a pipeline prioritization approach to...
PHARMA FORECASTING CASE STUDY – Estimating the Prevalence of Orphan Diseases
When in-house experts’ forecasts for the market potential of a treatment for an orphan disease conflicted, the management team...
Forecasting – Applying Pharmaceutical Valuation Approach in the Foster Care Setting
The Children’s Hospital of Philadelphia–Policy Lab approached Ozmosi for help in supporting its application for federal funding...
A Gift for Patients – Medicare to Cover Lung Cancer Screening
LUNG CANCER SCREENING UPDATE: As of February 5, 2015, effective immediately, Medicare will cover lung cancer screening by...
Building a Case Study Portfolio Framework
When a pharmaceutical company in China realized it needed outside help to identify and close the gaps in its R&D portfolio,...
We’re Back!
Ozmosi has been on a purpose-driven hiatus peppered with innovation, development and growth. In less than one year, we have...
Case Study Market Scan – Understanding the Competition and Defining Opportunity
A small startup medical device company needed a broader understanding of its potential competitors and a more complete picture...
Case Study Market Scan – Surveying Pharmaceutical Markets in Asia Pacific
A regional marketing team for a multinational pharmaceutical company needed a complete market overview of a neuroscience therapy...
7 Small-Cap Biotech Companies to Watch at AACR in April
We anticipate scientific reviews and clinical trial updates from 40 companies on nearly 80 oncology development programs at the...
Tango Therapeutics: Early Stage Oncology Pipeline Comes Into Focus in April
The Annual Meeting of the American Association for Cancer Research (AACR) is taking place April 5-10 in San Diego. AACR...
Market Overview: GLP-1 Agonists and the Obesity Market
Introduction to GLP-1 AgonistsGLP-1 agonists have been pivotal in the pharmaceutical market for nearly two decades, beginning...
Recent Tweets
🚀🚨 BIOPHARM CATALYST ALERT TOMORROW !!! 📆
👇👇👇
$HCM Sovleplenib - Phase III ESLIM-01 and Phase II/III ESLIM-02 studies of Syk inhibitor sovleplenib in immune thrombocytopenia ("ITP") and warm antibody autoimmune hemolytic anemia, ("wAIHA") respectively.
Get Started with OZMOSI
We synthesize and process insights, delivering what you need quickly, effectively, and efficiently.
600 Warren Ave,
Spring Lake, NJ 07762